Viridian Therapeutics Inc
LSE:0K1R
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Viridian Therapeutics Inc
LSE:0K1R
|
US |
|
AstraZeneca PLC
NYSE:AZN
|
UK |
Intrinsic Value
The intrinsic value for
Viridian Therapeutics Inc (0K1R) under the Base Case is 47.74 USD.
Compared with the current market price of 13.33 USD, the stock appears
Undervalued by 72% .
DCF suggests overvaluation, while multiples suggest undervaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Viridian Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Viridian Therapeutics Inc
Earnings Waterfall
Viridian Therapeutics Inc
The intrinsic value for
Viridian Therapeutics Inc (0K1R) under the Base Case is 47.74 USD.
Compared with the current market price of 13.33 USD, the stock appears Undervalued by 72% .